نتایج جستجو برای: core e1e2

تعداد نتایج: 215195  

Journal: :Antiviral therapy 2013
Clémence Arnaud Pierre Pradat Martina Spaziante Pascale Berthillon Marianne Maynard Gloria Taliani Isabelle Chemin Christian Trépo Marie-Anne Petit

BACKGROUND Unique serum anti-E1E2 antibodies were shown to be associated with spontaneous recovery or predictive of sustained virological response (SVR) in patients with chronic hepatitis C receiving pegylated interferon/ribavirin (PEG-IFN/RBV) therapy. The objectives were to establish the relationship between pretreatment anti-E1E2 titres and HCV RNA kinetics during PEG-IFN/RBV therapy, and to...

Journal: :Journal of virology 2011
Alexander W Tarr Richard A Urbanowicz Mohamed R Hamed Anna Albecka C Patrick McClure Richard J P Brown William L Irving Jean Dubuisson Jonathan K Ball

Neutralizing antibodies have a role in controlling hepatitis C virus (HCV) infection. A successful vaccine will need to elicit potently neutralizing antibodies that are capable of preventing the infection of genetically diverse viral isolates. However, the specificity of the neutralizing antibody response in natural HCV infection still is poorly understood. To address this, we examined the reac...

2011
Yuri Kasama Masaaki Satoh Makoto Saito Seiji Okada Chieko Kai Kyoko Tsukiyama-Kohara

Measles virus (MV) is a negative strand RNA virus of the family Paramyxoviridae, and the attenuated Edmonston-B strain can be engineered by the reverse genetics system. Here we constructed the recombinant Edmonston strain of measles virus (MV-Ed) that expressed hepatitis C virus (HCV) envelope proteins (rMV-E1E2). The rMV-E1E2 successfully expressed HCV E1 and E2 proteins. To evaluate its immun...

2017
Jihong Liu Clarke Lisa Paruch Mihaela‐Olivia Dobrica Iuliana Caras Catalin Tucureanu Adrian Onu Sonya Ciulean Crina Stavaru Andre Eerde Yanliang Wang Hege Steen Sissel Haugslien Catalina Petrareanu Catalin Lazar Costin‐Ioan Popescu Ralph Bock Jean Dubuisson Norica Branza‐Nichita

The hepatitis C virus (HCV) is a major etiologic agent for severe liver diseases (e.g. cirrhosis, fibrosis and hepatocellular carcinoma). Approximately 140 million people have chronic HCV infections and about 500 000 die yearly from HCV-related liver pathologies. To date, there is no licensed vaccine available to prevent HCV infection and production of a HCV vaccine remains a major challenge. H...

Journal: :Journal of virology 2007
Yann Ciczora Nathalie Callens François Penin Eve-Isabelle Pécheur Jean Dubuisson

The transmembrane (TM) domains of hepatitis C virus (HCV) envelope glycoproteins E1 and E2 have been shown to play multiple roles during the biogenesis of the E1E2 heterodimer. By using alanine scanning insertion mutagenesis within the TM domains of HCV envelope glycoproteins, we have previously shown that the central regions of these domains as well as the N-terminal part of the TM domain of E...

2016
Katarzyna Grzyb Anna Czarnota Agnieszka Brzozowska Anna Cieślik Łukasz Rąbalski Jolanta Tyborowska Krystyna Bieńkowska-Szewczyk

Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 are the main inducers of a cross-neutralizing antibody response which plays an important role in the early phase of viral infection. Correctly folded and immunologically active E1E2 complex can be expressed in mammalian cells, though the production process might still prove restrictive, even if the immunological response of a vaccine cand...

Journal: :Journal of virology 2012
Richard J P Brown Natalia Hudson Garrick Wilson Shafiq Ur Rehman Sara Jabbari Ke Hu Alexander W Tarr Persephone Borrow Michael Joyce Jamie Lewis Lin Fu Zhu Mansun Law Norman Kneteman D Lorne Tyrrell Jane A McKeating Jonathan K Ball

Genetic variability is a hallmark of RNA virus populations. However, transmission to a new host often results in a marked decrease in population diversity. This genetic bottlenecking is observed during hepatitis C virus (HCV) transmission and can arise via a selective sweep or through the founder effect. To model HCV transmission, we utilized chimeric SCID/Alb-uPA mice with transplanted human h...

Journal: :Journal of immunology 2001
N K Polakos D Drane J Cox P Ng M J Selby D Chien D T O'Hagan M Houghton X Paliard

Current therapies for the treatment of hepatitis C virus (HCV) infection are only effective in a restricted number of patients. Cellular immune responses, particularly those mediated by CD8(+) CTLs, are thought to play a role in the control of infection and the response to antiviral therapies. Because the Core protein is the most conserved HCV protein among genotypes, we evaluated the ability o...

1998
K. Geiger J. Ellis U. A. Wiedemann

A new treatment of Bose-Einstein correlations is incorporated in a space-time parton-shower model for ee annihilation into hadrons. Two alternative algorithms are discussed, and we use a simple calculable model to demonstrate that they reproduce successfully the size of the hadron emission region. One of the algorithms is used to calculate two-pion correlations in e1e2→Z0→hadrons and e1e2→W1W2→...

پایان نامه :وزارت علوم، تحقیقات و فناوری - دانشگاه تهران 1378

از جمله معروفترین آنتی بیوتیکهای ضدسرطان، می توان به آدریامایسین دانومایسین و اکتینومایسین d اشاره کرد. این داروها در معالجه سرطان از طریق شیمی درمانی مودر استفاده قرار می گیرند. هدف اصلی این داروها در سلول، مولکول dna است . از آنجا که مولکول dna در داخل هسته سلول به صورت برهنه و آزاد نیست بلکه در اتصال با ترکیبات دیگری مثل پروتئین های هسیتونی و غیرهیستونی می باشد، میان کنش این داروها با پروتئی...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید